Correlation of clinical activity of NEO201 mAb with the expression of NK activation markers and levels of soluble factors.

e15002Background: NEO-201 is a humanized IgG1 mAb that targets tumor-associated variants of CEACAM-5/6. NEO201 exerts anti-tumor activity by (NK)-mediated ADCC, CDC, and by enhancing NK cell cytoto...